ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

Burton’s Clinic Reported Operating In Spite of Closure

December 13, 1985

Rituximab Maintenance Improves Survival In Relapse

February 27, 2009

Cancer Control Program Guidelines Developed For Payment Of Patient Costs

December 21, 1973

In Brief: President Proposes $1,994 Billion For NCI;

February 10, 1995

ASCO, Pathologists Publish Guideline On Improving Accuracy Of HER2 Testing

December 29, 2006

In Brief: Durant New President Of AACI, Ultmann Named President-Elect; Farber Center Gets New Name

February 4, 1983